Skip to main content
Erschienen in:

24.11.2021 | Original Contributions

The Effect of Gastric Sleeve Resection on Menstrual Pattern and Ovulation in Premenopausal Women with Classes III–IV Obesity

verfasst von: Tetiana Tatarchuk, Ivan Todurov, Panagiotis Anagnostis, Tetiana Tutchenko, Natalia Pedachenko, Marina Glamazda, Natalia Koseii, Svetlana Regeda

Erschienen in: Obesity Surgery | Ausgabe 3/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Bariatric surgery is very efficacious in treating severe obesity. However, its effect on menstruation and ovulation is currently unknown. The purpose of this study was to assess the effect of gastric sleeve resection (GSR) on menstrual pattern in women with stages III–IV obesity and ovulatory dysfunction compared with conventional management.

Methods

This was a prospective, multicentre, non-randomized trial, in premenopausal women, who fulfilled the criteria for gastric sleeve resection (GSR). Both women with and without polycystic ovary syndrome (PCOS) were evaluated at 3, 6, 9, 12 and 15 months post-surgery.

Results

Menstrual cycle irregularities were identified in 122 severely obese women (60 with PCOS; 62 without PCOS). The % total weight loss was greater with GSR than with conventional management (33.4% vs. 3.6% in PCOS; 24.8% vs. 3.6% in non-PCOS, respectively). Intermenstrual interval was shortened towards normal length (≤ 35 days) both in PCOS and non-PCOS GSR groups, by the 6th and 12th post-surgical month, respectively. Furthermore, ovulation at 6 months was achieved in 63.6% of PCOS and 45% of non-PCOS subjects post-GSR, which was higher than in controls (11.1% and 13.6%, respectively; p < 0.05). This percentage rose to 75.7% and 81.8% at 12 and 15 months in PCOS, respectively, but not in the non-PCOS group (55% and 52.5%, respectively; p < 0.05).

Conclusions

Weight reduction after GSR improved menstrual irregularity towards normality in women with severe obesity. Ovulation dysfunction was also resumed in more than half of these patients at 6–15 months. These effects were more evident in women with PCOS.

Graphical abstract

Literatur
2.
Zurück zum Zitat Bouter KE, van Raalte DH, Groen AK, Nieuwdorp M. Role of the gut microbiome in the pathogenesis of obesity and obesity-related metabolic dysfunction. Gastroenterology. 2017;152:1671–8.CrossRef Bouter KE, van Raalte DH, Groen AK, Nieuwdorp M. Role of the gut microbiome in the pathogenesis of obesity and obesity-related metabolic dysfunction. Gastroenterology. 2017;152:1671–8.CrossRef
3.
Zurück zum Zitat Gonzalez-Casanova JE, Pertuz-Cruz SL, Caicedo-Ortega NH, Rojas-Gomez DM. Adipogenesis regulation and endocrine disruptors: emerging insights in obesity. Biomed Res Int. 2020;2020:7453786.CrossRef Gonzalez-Casanova JE, Pertuz-Cruz SL, Caicedo-Ortega NH, Rojas-Gomez DM. Adipogenesis regulation and endocrine disruptors: emerging insights in obesity. Biomed Res Int. 2020;2020:7453786.CrossRef
4.
Zurück zum Zitat Kopp W. Development of Obesity: The Driver and the Passenger. Diabetes Metab Syndr Obes. 2020;13:4631–42.CrossRef Kopp W. Development of Obesity: The Driver and the Passenger. Diabetes Metab Syndr Obes. 2020;13:4631–42.CrossRef
5.
Zurück zum Zitat Di Lorenzo N, Antoniou SA, Batterham RL, et al. Clinical practice guidelines of the European Association for Endoscopic Surgery (EAES) on bariatric surgery: update 2020 endorsed by IFSO-EC, EASO and ESPCOP. Surg Endosc. 2020;34:2332–58.CrossRef Di Lorenzo N, Antoniou SA, Batterham RL, et al. Clinical practice guidelines of the European Association for Endoscopic Surgery (EAES) on bariatric surgery: update 2020 endorsed by IFSO-EC, EASO and ESPCOP. Surg Endosc. 2020;34:2332–58.CrossRef
6.
Zurück zum Zitat Poulose BK, Holzman MD, Zhu Y, Smalley W, Richards WO, Wright JK, Melvin W, Griffin MR. National variations in morbid obesity and bariatric surgery use. J Am Coll Surg. 2005;201:77–84.CrossRef Poulose BK, Holzman MD, Zhu Y, Smalley W, Richards WO, Wright JK, Melvin W, Griffin MR. National variations in morbid obesity and bariatric surgery use. J Am Coll Surg. 2005;201:77–84.CrossRef
7.
Zurück zum Zitat Sturm R, Hattori A. Morbid obesity rates continue to rise rapidly in the United States. Int J Obes (Lond). 2013;37:889–91.CrossRef Sturm R, Hattori A. Morbid obesity rates continue to rise rapidly in the United States. Int J Obes (Lond). 2013;37:889–91.CrossRef
8.
Zurück zum Zitat Janssen F, Bardoutsos A, Vidra N. Obesity prevalence in the long-term future in 18 European countries and in the USA. Obes Facts. 2020;13:514–27.CrossRef Janssen F, Bardoutsos A, Vidra N. Obesity prevalence in the long-term future in 18 European countries and in the USA. Obes Facts. 2020;13:514–27.CrossRef
9.
Zurück zum Zitat Conway GS, Agrawal R, Betteridge DJ, Jacobs HS. Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome. Clin Endocrinol (Oxf). 1992;37:119–25.CrossRef Conway GS, Agrawal R, Betteridge DJ, Jacobs HS. Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome. Clin Endocrinol (Oxf). 1992;37:119–25.CrossRef
10.
Zurück zum Zitat Silvestris E, de Pergola G, Rosania R, Loverro G. Obesity as disruptor of the female fertility. Reprod Biol Endocrinol. 2018;16:22.CrossRef Silvestris E, de Pergola G, Rosania R, Loverro G. Obesity as disruptor of the female fertility. Reprod Biol Endocrinol. 2018;16:22.CrossRef
11.
Zurück zum Zitat Rachon D, Teede H. Ovarian function and obesity–interrelationship, impact on women’s reproductive lifespan and treatment options. Mol Cell Endocrinol. 2010;316:172–9.CrossRef Rachon D, Teede H. Ovarian function and obesity–interrelationship, impact on women’s reproductive lifespan and treatment options. Mol Cell Endocrinol. 2010;316:172–9.CrossRef
12.
Zurück zum Zitat Kumbak B, Oral E, Bukulmez O. Female obesity and assisted reproductive technologies. Semin Reprod Med. 2012;30:507–16.CrossRef Kumbak B, Oral E, Bukulmez O. Female obesity and assisted reproductive technologies. Semin Reprod Med. 2012;30:507–16.CrossRef
13.
Zurück zum Zitat Purewal S, Chapman SCE, van den Akker OBA. A systematic review and meta-analysis of lifestyle and body mass index predictors of successful assisted reproductive technologies. J Psychosom Obstet Gynaecol. 2019;40:2–18.CrossRef Purewal S, Chapman SCE, van den Akker OBA. A systematic review and meta-analysis of lifestyle and body mass index predictors of successful assisted reproductive technologies. J Psychosom Obstet Gynaecol. 2019;40:2–18.CrossRef
14.
Zurück zum Zitat Arterburn DE, Courcoulas AP. Bariatric surgery for obesity and metabolic conditions in adults. BMJ. 2014;349:g3961.CrossRef Arterburn DE, Courcoulas AP. Bariatric surgery for obesity and metabolic conditions in adults. BMJ. 2014;349:g3961.CrossRef
15.
Zurück zum Zitat Khan S, Rock K, Baskara A, Qu W, Nazzal M, Ortiz J. Trends in bariatric surgery from 2008 to 2012. Am J Surg. 2016;211:1041–6.CrossRef Khan S, Rock K, Baskara A, Qu W, Nazzal M, Ortiz J. Trends in bariatric surgery from 2008 to 2012. Am J Surg. 2016;211:1041–6.CrossRef
16.
Zurück zum Zitat Escobar-Morreale HF, Santacruz E, Luque-Ramirez M, Botella Carretero JI. Prevalence of ‘obesity-associated gonadal dysfunction’ in severely obese men and women and its resolution after bariatric surgery: a systematic review and meta-analysis. Hum Reprod Update. 2017;23:390–408.CrossRef Escobar-Morreale HF, Santacruz E, Luque-Ramirez M, Botella Carretero JI. Prevalence of ‘obesity-associated gonadal dysfunction’ in severely obese men and women and its resolution after bariatric surgery: a systematic review and meta-analysis. Hum Reprod Update. 2017;23:390–408.CrossRef
17.
Zurück zum Zitat Milone M, Sosa Fernandez LM, Sosa Fernandez LV, Manigrasso M, Elmore U, De Palma GD, Musella M, Milone F. Does bariatric surgery improve assisted reproductive technology outcomes in obese infertile women? Obes Surg. 2017;27:2106–12.CrossRef Milone M, Sosa Fernandez LM, Sosa Fernandez LV, Manigrasso M, Elmore U, De Palma GD, Musella M, Milone F. Does bariatric surgery improve assisted reproductive technology outcomes in obese infertile women? Obes Surg. 2017;27:2106–12.CrossRef
18.
Zurück zum Zitat Fried M, Yumuk V, Oppert JM, et al. Interdisciplinary European guidelines on metabolic and bariatric surgery. Obes Surg. 2014;24:42–55.CrossRef Fried M, Yumuk V, Oppert JM, et al. Interdisciplinary European guidelines on metabolic and bariatric surgery. Obes Surg. 2014;24:42–55.CrossRef
19.
Zurück zum Zitat Shawe J, Ceulemans D, Akhter Z, et al. Pregnancy after bariatric surgery: consensus recommendations for periconception, antenatal and postnatal care. Obes Rev. 2019;20:1507–22.CrossRef Shawe J, Ceulemans D, Akhter Z, et al. Pregnancy after bariatric surgery: consensus recommendations for periconception, antenatal and postnatal care. Obes Rev. 2019;20:1507–22.CrossRef
20.
Zurück zum Zitat Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, Piltonen T, Norman RJ, International PN (2018) Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Clin Endocrinol (Oxf) 89:251-268 Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, Piltonen T, Norman RJ, International PN (2018) Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Clin Endocrinol (Oxf) 89:251-268
21.
Zurück zum Zitat Mojiminiyi OA, Abdella NA. Effect of homeostasis model assessment computational method on the definition and associations of insulin resistance. Clin Chem Lab Med. 2010;48:1629–34.CrossRef Mojiminiyi OA, Abdella NA. Effect of homeostasis model assessment computational method on the definition and associations of insulin resistance. Clin Chem Lab Med. 2010;48:1629–34.CrossRef
22.
Zurück zum Zitat Sermondade N, Huberlant S, Bourhis-Lefebvre V, Arbo E, Gallot V, Colombani M, Freour T. Female obesity is negatively associated with live birth rate following IVF: a systematic review and meta-analysis. Hum Reprod Update. 2019;25:439–51.CrossRef Sermondade N, Huberlant S, Bourhis-Lefebvre V, Arbo E, Gallot V, Colombani M, Freour T. Female obesity is negatively associated with live birth rate following IVF: a systematic review and meta-analysis. Hum Reprod Update. 2019;25:439–51.CrossRef
23.
Zurück zum Zitat Moxthe LC, Sauls R, Ruiz M, Stern M, Gonzalvo J, Gray HL. Effects of bariatric surgeries on male and female fertility: a systematic review. J Reprod Infertil. 2020;21:71–86.PubMedPubMedCentral Moxthe LC, Sauls R, Ruiz M, Stern M, Gonzalvo J, Gray HL. Effects of bariatric surgeries on male and female fertility: a systematic review. J Reprod Infertil. 2020;21:71–86.PubMedPubMedCentral
24.
Zurück zum Zitat Li YJ, Han Y, He B. Effects of bariatric surgery on obese polycystic ovary syndrome: a systematic review and meta-analysis. Surg Obes Relat Dis. 2019;15:942–50.CrossRef Li YJ, Han Y, He B. Effects of bariatric surgery on obese polycystic ovary syndrome: a systematic review and meta-analysis. Surg Obes Relat Dis. 2019;15:942–50.CrossRef
25.
Zurück zum Zitat Wang J, Wu D, Guo H, Li M. Hyperandrogenemia and insulin resistance: the chief culprit of polycystic ovary syndrome. Life Sci. 2019;236:116940.CrossRef Wang J, Wu D, Guo H, Li M. Hyperandrogenemia and insulin resistance: the chief culprit of polycystic ovary syndrome. Life Sci. 2019;236:116940.CrossRef
26.
Zurück zum Zitat Butzow TL, Lehtovirta M, Siegberg R, Hovatta O, Koistinen R, Seppala M, Apter D. The decrease in luteinizing hormone secretion in response to weight reduction is inversely related to the severity of insulin resistance in overweight women. J Clin Endocrinol Metab. 2000;85:3271–5.PubMed Butzow TL, Lehtovirta M, Siegberg R, Hovatta O, Koistinen R, Seppala M, Apter D. The decrease in luteinizing hormone secretion in response to weight reduction is inversely related to the severity of insulin resistance in overweight women. J Clin Endocrinol Metab. 2000;85:3271–5.PubMed
27.
Zurück zum Zitat Van Dam EW, Roelfsema F, Veldhuis JD, Helmerhorst FM, Frolich M, Meinders AE, Krans HM, Pijl H. Increase in daily LH secretion in response to short-term calorie restriction in obese women with PCOS. Am J Physiol Endocrinol Metab. 2002;282:E865-872.CrossRef Van Dam EW, Roelfsema F, Veldhuis JD, Helmerhorst FM, Frolich M, Meinders AE, Krans HM, Pijl H. Increase in daily LH secretion in response to short-term calorie restriction in obese women with PCOS. Am J Physiol Endocrinol Metab. 2002;282:E865-872.CrossRef
28.
Zurück zum Zitat Pirke KM, Schweiger U, Lemmel W, Krieg JC, Berger M. The influence of dieting on the menstrual cycle of healthy young women. J Clin Endocrinol Metab. 1985;60:1174–9.CrossRef Pirke KM, Schweiger U, Lemmel W, Krieg JC, Berger M. The influence of dieting on the menstrual cycle of healthy young women. J Clin Endocrinol Metab. 1985;60:1174–9.CrossRef
29.
Zurück zum Zitat Parrettini S, Cavallo M, Gaggia F, Calafiore R, Luca G. Adipokines: a rainbow of proteins with metabolic and endocrine functions. Protein Pept Lett. 2020;27:1204–30.CrossRef Parrettini S, Cavallo M, Gaggia F, Calafiore R, Luca G. Adipokines: a rainbow of proteins with metabolic and endocrine functions. Protein Pept Lett. 2020;27:1204–30.CrossRef
30.
Zurück zum Zitat Park HK, Ahima RS. Physiology of leptin: energy homeostasis, neuroendocrine function and metabolism. Metabolism. 2015;64:24–34.CrossRef Park HK, Ahima RS. Physiology of leptin: energy homeostasis, neuroendocrine function and metabolism. Metabolism. 2015;64:24–34.CrossRef
31.
Zurück zum Zitat Dobrzyn K, Smolinska N, Kiezun M, Szeszko K, Rytelewska E, Kisielewska K, Gudelska M, Kaminski T. Adiponectin: a new regulator of female reproductive system. Int J Endocrinol. 2018;2018:7965071.CrossRef Dobrzyn K, Smolinska N, Kiezun M, Szeszko K, Rytelewska E, Kisielewska K, Gudelska M, Kaminski T. Adiponectin: a new regulator of female reproductive system. Int J Endocrinol. 2018;2018:7965071.CrossRef
32.
Zurück zum Zitat Anagnostis P, Athyros VG, Kita M, Karagiannis A. Is there any association between adiponectin gene polymorphisms and cardiovascular disease? Angiology. 2013;64:253–6.CrossRef Anagnostis P, Athyros VG, Kita M, Karagiannis A. Is there any association between adiponectin gene polymorphisms and cardiovascular disease? Angiology. 2013;64:253–6.CrossRef
33.
Zurück zum Zitat Athyros VG, Tziomalos K, Karagiannis A, Anagnostis P, Mikhailidis DP. Should adipokines be considered in the choice of the treatment of obesity-related health problems? Curr Drug Targets. 2010;11:122–35.CrossRef Athyros VG, Tziomalos K, Karagiannis A, Anagnostis P, Mikhailidis DP. Should adipokines be considered in the choice of the treatment of obesity-related health problems? Curr Drug Targets. 2010;11:122–35.CrossRef
34.
Zurück zum Zitat Askarpour M, Alizadeh S, Hadi A, Symonds ME, Miraghajani M, Sheikhi A, Ghaedi E. Effect of bariatric surgery on the circulating level of adiponectin, chemerin, plasminogen activator inhibitor-1, leptin, resistin, and visfatin: a systematic review and meta-analysis. Horm Metab Res. 2020;52:207–15.CrossRef Askarpour M, Alizadeh S, Hadi A, Symonds ME, Miraghajani M, Sheikhi A, Ghaedi E. Effect of bariatric surgery on the circulating level of adiponectin, chemerin, plasminogen activator inhibitor-1, leptin, resistin, and visfatin: a systematic review and meta-analysis. Horm Metab Res. 2020;52:207–15.CrossRef
35.
Zurück zum Zitat Karlsson HK, Tuulari JJ, Tuominen L, Hirvonen J, Honka H, Parkkola R, Helin S, Salminen P, Nuutila P, Nummenmaa L. Weight loss after bariatric surgery normalizes brain opioid receptors in morbid obesity. Mol Psychiatry. 2016;21:1057–62.CrossRef Karlsson HK, Tuulari JJ, Tuominen L, Hirvonen J, Honka H, Parkkola R, Helin S, Salminen P, Nuutila P, Nummenmaa L. Weight loss after bariatric surgery normalizes brain opioid receptors in morbid obesity. Mol Psychiatry. 2016;21:1057–62.CrossRef
36.
Zurück zum Zitat Lambrinoudaki I, Stergiotis S, Chatzivasileiou P, et al. Anti-Mullerian hormone concentrations are inversely associated with subclinical atherosclerosis in premenopausal women. Angiology. 2020;71:552–8.CrossRef Lambrinoudaki I, Stergiotis S, Chatzivasileiou P, et al. Anti-Mullerian hormone concentrations are inversely associated with subclinical atherosclerosis in premenopausal women. Angiology. 2020;71:552–8.CrossRef
37.
Zurück zum Zitat Nilsson-Condori E, Hedenbro JL, Thurin-Kjellberg A, Giwercman A, Friberg B. Impact of diet and bariatric surgery on anti-Mullerian hormone levels. Hum Reprod. 2018;33:690–3.CrossRef Nilsson-Condori E, Hedenbro JL, Thurin-Kjellberg A, Giwercman A, Friberg B. Impact of diet and bariatric surgery on anti-Mullerian hormone levels. Hum Reprod. 2018;33:690–3.CrossRef
38.
Zurück zum Zitat Pilone V, Tramontano S, Renzulli M, Monda A, Cutolo C, Romano M, Schiavo L. Evaluation of anti-Muller hormone AMH levels in obese women after sleeve gastrectomy. Gynecol Endocrinol. 2019;35:548–51.CrossRef Pilone V, Tramontano S, Renzulli M, Monda A, Cutolo C, Romano M, Schiavo L. Evaluation of anti-Muller hormone AMH levels in obese women after sleeve gastrectomy. Gynecol Endocrinol. 2019;35:548–51.CrossRef
39.
Zurück zum Zitat Reinehr T, Kulle A, Rothermel J, Knop C, Lass N, Bosse C, Holterhus PM. Weight loss in obese girls with polycystic ovarian syndrome is associated with a decrease in Anti-Muellerian Hormone concentrations. Clin Endocrinol (Oxf). 2017;87:185–93.CrossRef Reinehr T, Kulle A, Rothermel J, Knop C, Lass N, Bosse C, Holterhus PM. Weight loss in obese girls with polycystic ovarian syndrome is associated with a decrease in Anti-Muellerian Hormone concentrations. Clin Endocrinol (Oxf). 2017;87:185–93.CrossRef
40.
Zurück zum Zitat Vincentelli C, Maraninchi M, Valero R, et al. One-year impact of bariatric surgery on serum anti-Mullerian-hormone levels in severely obese women. J Assist Reprod Genet. 2018;35:1317–24.CrossRef Vincentelli C, Maraninchi M, Valero R, et al. One-year impact of bariatric surgery on serum anti-Mullerian-hormone levels in severely obese women. J Assist Reprod Genet. 2018;35:1317–24.CrossRef
41.
Zurück zum Zitat Shekelle PG, Newberry S, Maglione M, et al. (2008) Bariatric surgery in women of reproductive age: special concerns for pregnancy. Evid Rep Technol Assess (Full Rep) 1–51 Shekelle PG, Newberry S, Maglione M, et al. (2008) Bariatric surgery in women of reproductive age: special concerns for pregnancy. Evid Rep Technol Assess (Full Rep) 1–51
42.
Zurück zum Zitat Ciangura C, Coupaye M, Deruelle P, et al. Clinical practice guidelines for childbearing female candidates for bariatric surgery, pregnancy, and post-partum management after bariatric surgery. Obes Surg. 2019;29:3722–34.CrossRef Ciangura C, Coupaye M, Deruelle P, et al. Clinical practice guidelines for childbearing female candidates for bariatric surgery, pregnancy, and post-partum management after bariatric surgery. Obes Surg. 2019;29:3722–34.CrossRef
Metadaten
Titel
The Effect of Gastric Sleeve Resection on Menstrual Pattern and Ovulation in Premenopausal Women with Classes III–IV Obesity
verfasst von
Tetiana Tatarchuk
Ivan Todurov
Panagiotis Anagnostis
Tetiana Tutchenko
Natalia Pedachenko
Marina Glamazda
Natalia Koseii
Svetlana Regeda
Publikationsdatum
24.11.2021
Verlag
Springer US
Erschienen in
Obesity Surgery / Ausgabe 3/2022
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-021-05820-0

Neu im Fachgebiet Chirurgie

Nur selten ernste Komplikationen bei endoskopischer Sinuschirurgie

Etwa 3% der Menschen mit einer endoskopischen Nasennebenhöhlenoperation entwickeln ausgeprägtes Nasenbluten. Andere Komplikationen, wie Verletzungen des Nervus opticus oder eine Meningitis, treten nur äußerst selten auf, legt eine Registeranalyse nahe.

Hochrisiko-Spinaliom am besten mit der Mohs-Chirurgie entfernen

Die Mohs-Chirurgie ist zwar mit mehr Aufwand verbunden als die herkömmliche Exzision; für die Versorgung kutaner Hochrisiko-Plattenepithelkarzinome lohnt sich die zeitintensive Technik aber in jedem Fall. Laut einer aktuellen Studie sinkt im Vergleich das Sterberisiko.

Mechanische Herzklappe beschert jüngeren Betroffenen längeres Leben

Patienten und Patientinnen bevorzugen bioprothetische Herzklappen gegenüber mechanischen Klappenprothesen. Diese Wahl könnte sich zumindest für jüngere Patienten nachteilig auswirken: Ihnen bietet eine mechanische Klappe anscheinend einen Überlebensvorteil.

Darmpolyp weg – Peptid-Gel gegen Nachblutungen drauf?

Das Nachblutungsrisiko nach einer endoskopischen Mukosaresektion von flachen kolorektalen und duodenalen Adenomen war in der deutschen PURPLE-Studie mit einem hämostatischen Gel nicht kleiner als ohne Prophylaxe.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.